Logotype for Divi’s Laboratories Limited

Divi’s Laboratories (DIVISLAB) Q2 26/27 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Divi’s Laboratories Limited

Q2 26/27 earnings summary

7 Nov, 2026

Executive summary

  • Q2 FY27 consolidated total income rose 32% YoY to ₹3,770 crore; PBT increased 65% to ₹1,505 crore and PAT increased 64% to ₹1,127 crore.

  • H1 FY27 consolidated total income was ₹6,907 crore, PBT ₹2,685 crore and PAT ₹2,029 crore, versus ₹5,389 crore, ₹1,645 crore and ₹1,234 crore, respectively, a year earlier.

Financial highlights

  • Consolidated Q2 FY27 revenue from operations was ₹3,676 crore versus ₹2,715 crore in Q2 FY26; H1 revenue was ₹6,756 crore versus ₹5,125 crore.

  • Standalone H1 revenue grew 17% YoY on a constant-currency basis; exports were ~90% of standalone sales, with Europe and North America contributing ~75%.

  • H1 nutraceutical revenue was ₹571 crore versus ₹492 crore YoY.

  • H1 consolidated forex gain was ₹17 crore versus ₹102 crore; at Sep. 30, 2026, cash was ₹2,181 crore, receivables ₹3,705 crore and inventories ₹5,325 crore.

  • Consolidated EPS was ₹42.49 in Q2 FY27 and ₹76.44 in H1 FY27, versus ₹25.97 and ₹46.46 in the prior-year periods; figures are not annualized.

Outlook and guidance

  • Revenue growth guidance remains double-digit; management gave no narrower H2 range and did not raise its prior EBITDA margin guidance.

  • Annual CapEx outlook is ~₹2,000 crore, +/-20%, over the next two to three years, based on RFPs and customer opportunities.

  • Three major dedicated projects are progressing through qualification; one is near commercialization and two are expected to commercialize over the next few quarters, subject to approvals.

  • No capacity shortage is currently expected; capacity additions are planned with customers and in response to opportunities.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from Divi’s Laboratories